A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Conditions: Chronic Plaque Psoriasis; Moderate to Severe Chronic Plaque Psoriasis Interventions: Other: Placebo; Drug: Bimekizumab Sponsor: UCB Biopharma SRL Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials